Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001127602-21-031141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-16 | 2021-12-14 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | A - Grant | $0.00 | +5,850 | 11.2K | +109% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | A - Grant | $0.00 | +11.7K | 11.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | A | A | 5,850 | $0.00 | 11,198 | D | — | — | (F1) Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. |
| 2 | Derivative | Emp. Stock Option (Right to Buy) | 2021-12-14 | A | A | 11,700 | $0.00 | 11,700 | D | $11.43 · 2022-12-14 to 2031-12-14 | 11,700 Common Stock | (F2) Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. |